Τhe project titled “Pre-clinical evaluation of the therapeutic potential of novel compounds in ovarian cancer” and acronym PRETORIAN has been selected for funding by the Greek General Secretariat for Research and Technology (European Union, European Regional Development Fund, ESPA, Partnership Agreement, 2014-2020, EPAnEK, 2014-2020, Operational Program: Competitiveness, Entrepreneurship, Innovation).

Funding Agency

Greek General Secretariat for Research and Technology

Path

Collaboration of businesses with research institutions

Priority Area

Pharmaceuticals

«Co‐financed by the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call RESEARCH – CREATE – INNOVATE (project code: T2EDK-02364, total funding: 890.272,14 €, support period: 2021-2023)»